After trial success, Alnylam plans to seek FDA approval for 2nd drug By: Boston Business Journal via Business Journals March 06, 2019 at 08:20 AM EST The company announced Wednesday that its drug givosiran met its primary endpoints in a Phase 3 trial. Read More >>